Breathing easy with pathogen inactivation

被引:3
作者
AuBuchon, James P.
机构
关键词
PLATELET; SAFETY; TRIAL; TRANSFUSION; REDUCTION;
D O I
10.1182/blood-2010-11-313379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:749 / 751
页数:5
相关论文
共 11 条
[1]  
AuBuchon JP, 2010, PATHOGEN INACTIVATIO
[2]   A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology [J].
Cazenave, J. -P ;
Follea, G. ;
Bardiaux, L. ;
Boiron, J. -M. ;
Lafeuillade, B. ;
Debost, M. ;
Lioure, B. ;
Harousseau, J. -L. ;
Tabrizi, R. ;
Cahn, J. -Y ;
Michallet, M. ;
Ambruso, D. ;
Schots, R. ;
Tissot, J. -D. ;
Sensebe, L. ;
Kondo, T. ;
McCullough, J. ;
Rebulla, P. ;
Escolar, G. ;
Mintz, P. ;
Heddle, N. M. ;
Goodrich, R. P. ;
Bruhwyler, J. ;
Le, C. ;
Cook, R. J. ;
Stouch, B. .
TRANSFUSION, 2010, 50 (11) :2362-2375
[3]   Determination of acute lung injury after repeated platelet transfusions [J].
Corash, Laurence ;
Lin, Jin Sying ;
Sherman, Claire D. ;
Eiden, Joseph .
BLOOD, 2011, 117 (03) :1014-1020
[4]   Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006) [J].
Eder, Anne F. ;
Kennedy, Jean M. ;
Dy, Beth A. ;
Notari, Edward P. ;
Weiss, John W. ;
Fang, Chyang T. ;
Wagner, Stephen ;
Dodd, Roger Y. ;
Benjamin, Richard J. .
TRANSFUSION, 2007, 47 (07) :1134-1142
[5]   Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction [J].
Kerkhoffs, Jean-Louis H. ;
van Putten, Wim L. J. ;
Novotny, Viera M. J. ;
Boekhorst, Peter A. W. Te ;
Schipperus, Martin R. ;
Zwaginga, Jaap Jan ;
van Pampus, Lizzy C. M. ;
de Greef, Georgine E. ;
Luten, Marleen ;
Huijgens, Peter C. ;
Brand, Anneke ;
van Rhenen, Dick J. .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (02) :209-217
[6]   Pathogen inactivation: making decisions about new technologies - Report of a consensus conference [J].
Klein, Harvey G. ;
Anderson, David ;
Bernardi, Marie-Josee ;
Cable, Ritchard ;
Carey, William ;
Hoch, Jeffrey S. ;
Robitaille, Nancy ;
Sivilotti, Marco L. A. ;
Smaill, Fiona .
TRANSFUSION, 2007, 47 (12) :2338-2347
[7]   Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial [J].
McCullough, J ;
Vesole, DH ;
Benjamin, RJ ;
Slichter, SJ ;
Pineda, A ;
Snyder, E ;
Stadtmauer, EA ;
Lopez-Plaza, I ;
Coutre, S ;
Strauss, RG ;
Goodnough, LT ;
Fridey, JL ;
Raife, T ;
Cable, R ;
Murphy, S ;
Howard, F ;
Davis, K ;
Lin, JS ;
Metzel, P ;
Corash, L ;
Koutsoukos, A ;
Lin, L ;
Buchholz, DH ;
Conlan, MG .
BLOOD, 2004, 104 (05) :1534-1541
[8]   Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety [J].
Murphy, W. G. ;
Foley, M. ;
Doherty, C. ;
Tierney, G. ;
Kinsella, A. ;
Salami, A. ;
Cadden, E. ;
Coakley, P. .
VOX SANGUINIS, 2008, 95 (01) :13-19
[9]   An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment [J].
Osselaer, J. C. ;
Cazenave, J. P. ;
Lambermont, M. ;
Garraud, O. ;
Hidajat, M. ;
Barbolla, L. ;
Tardivel, R. ;
Defoin, L. ;
Waller, C. ;
Mendel, I. ;
Raidot, J. P. ;
Kandel, G. ;
De Meuter, R. ;
Fabrigli, P. ;
Dehenau, D. ;
Arroyo, J. L. ;
Padron, F. ;
Gouezec, H. ;
Corral, M. ;
Jacquet, M. ;
Sundin, D. ;
Lin, L. ;
Corash, L. .
VOX SANGUINIS, 2008, 94 (04) :315-323
[10]   Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use [J].
Osselaer, Jean Claude ;
Doyen, Chantal ;
Defoin, Laurence ;
Debry, Cecile ;
Goffaux, Maite ;
Messe, Nathalie ;
Van Hooydonk, Maryse ;
Bosly, Andre ;
Lin, Jin Sying ;
Lin, Lily ;
Corash, Laurence .
TRANSFUSION, 2009, 49 (07) :1412-1422